tiprankstipranks
Recordati Industria Chimica e Farmaceutica SPA (IT:REC)
:REC
Italy Market
Want to see IT:REC full AI Analyst Report?

Recordati Industria Chimica e Farmaceutica SPA (REC) Stock Forecast & Price Target

17 Followers
See the Price Targets and Ratings of:

REC Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Recordati
Industria Chimica e Farmaceutica SPA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

REC Stock 12 Month Forecast

There Are No Analyst Ratings for IT:REC In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

REC Financial Forecast

REC Earnings Forecast

The previous quarter’s earnings for REC were €0.73.
The previous quarter’s earnings for REC were €0.73.

REC Sales Forecast

Next quarter’s sales forecast for REC is €679.70M with a range of €676.40M to €685.70M. The previous quarter’s sales results were €713.42M. REC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year REC has Performed in-line its overall industry.
Next quarter’s sales forecast for REC is €679.70M with a range of €676.40M to €685.70M. The previous quarter’s sales results were €713.42M. REC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year REC has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on IT:REC
Kepler Capital
Kepler Capital
€57.5
Buy
14.09%
Upside
Reiterated
04/21/26
Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Exane BNP Paribas Analyst forecast on IT:REC
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
€56
Buy
11.11%
Upside
Initiated
03/03/26
Recordati Industria initiated with an Outperform at BNP ParibasRecordati Industria initiated with an Outperform at BNP Paribas
Barclays
€48
Hold
-4.76%
Downside
Upgraded
02/12/26
Recordati Industria upgraded to Equal Weight from Underweight at BarclaysRecordati Industria upgraded to Equal Weight from Underweight at Barclays
J.P. Morgan Analyst forecast on IT:REC
J.P. Morgan
J.P. Morgan
€67€70
Buy
38.89%
Upside
Reiterated
12/08/25
Recordati price target raised to EUR 70 from EUR 67 at JPMorganRecordati price target raised to EUR 70 from EUR 67 at JPMorgan
RBC Capital
€56
Hold
11.11%
Upside
Reiterated
08/11/25
RBC Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Jefferies Analyst forecast on IT:REC
Jefferies
Jefferies
€61.5
Buy
22.02%
Upside
Upgraded
08/11/25
Optimistic Growth Prospects for Recordati Industria Chimica e Farmaceutica SPA: Buy Rating Affirmed
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on IT:REC
Kepler Capital
Kepler Capital
€57.5
Buy
14.09%
Upside
Reiterated
04/21/26
Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Exane BNP Paribas Analyst forecast on IT:REC
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
€56
Buy
11.11%
Upside
Initiated
03/03/26
Recordati Industria initiated with an Outperform at BNP ParibasRecordati Industria initiated with an Outperform at BNP Paribas
Barclays
€48
Hold
-4.76%
Downside
Upgraded
02/12/26
Recordati Industria upgraded to Equal Weight from Underweight at BarclaysRecordati Industria upgraded to Equal Weight from Underweight at Barclays
J.P. Morgan Analyst forecast on IT:REC
J.P. Morgan
J.P. Morgan
€67€70
Buy
38.89%
Upside
Reiterated
12/08/25
Recordati price target raised to EUR 70 from EUR 67 at JPMorganRecordati price target raised to EUR 70 from EUR 67 at JPMorgan
RBC Capital
€56
Hold
11.11%
Upside
Reiterated
08/11/25
RBC Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Jefferies Analyst forecast on IT:REC
Jefferies
Jefferies
€61.5
Buy
22.02%
Upside
Upgraded
08/11/25
Optimistic Growth Prospects for Recordati Industria Chimica e Farmaceutica SPA: Buy Rating Affirmed
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Recordati Industria Chimica e Farmaceutica SPA

3 Months
Niccolo Guido StorerKepler Capital
Success Rate
3/3 ratings generated profit
100%
Average Return
+5.07%
Copying Niccolo Guido Storer's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.07% per trade.
1 Year
Niccolo Guido StorerKepler Capital
Success Rate
3/3 ratings generated profit
100%
Average Return
+6.73%
Copying Niccolo Guido Storer's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.73% per trade.
2 Years
Niccolo Guido StorerKepler Capital
Success Rate
3/3 ratings generated profit
100%
Average Return
+6.73%
Copying Niccolo Guido Storer's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +6.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

REC Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
4
5
3
1
0
Hold
1
1
0
0
0
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
3
1
0
In the current month, REC has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. REC average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

REC Stock Forecast FAQ

What is IT:REC’s average 12-month price target, according to analysts?
Currently, no data Available
What is IT:REC’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IT:REC, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Recordati Industria Chimica e Farmaceutica SPA a Buy, Sell or Hold?
      Currently, no data Available
      What is Recordati Industria Chimica e Farmaceutica SPA’s share price target?
      Currently, no data Available
      What do analysts say about Recordati Industria Chimica e Farmaceutica SPA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Recordati Industria Chimica e Farmaceutica SPA?
      To buy shares of IT:REC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.